NIDA is offering a grant to fund research on synthetic psychoactive drugs, focusing on understanding their mechanisms of action, health effects, and developing prevention and treatment strategies. This grant aims to advance knowledge on these substances and improve patient care in emergency departments and long-term treatment. The closing date for applications is May 07, 2020.
Opportunity ID: 299507
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-18-509 |
Funding Opportunity Title: | Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional ) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Dec 18, 2017 |
Last Updated Date: | – |
Original Closing Date for Applications: | May 07, 2020 |
Current Closing Date for Applications: | May 07, 2020 |
Archive Date: | Jun 12, 2020 |
Estimated Total Program Funding: | – |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Small businesses City or township governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this FOA is to support research to deepen our knowledge of the use of synthetic psychoactive drugs, their mechanisms of action, their health effects, and development of prevention strategies and strategies to treat patients in emergency departments and long range treatment. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-509.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237132 | Jan 16, 2018 | May 24, 2020 | View | |
FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260006 | Jan 16, 2018 | May 07, 2020 | View |
Package 1
Mandatory forms
299507 RR_SF424_2_0-2.0.pdf
299507 PHS398_CoverPageSupplement_4_0-4.0.pdf
299507 RR_OtherProjectInfo_1_4-1.4.pdf
299507 PerformanceSite_2_0-2.0.pdf
299507 RR_KeyPersonExpanded_2_0-2.0.pdf
299507 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299507 RR_Budget_1_4-1.4.pdf
299507 RR_SubawardBudget30_1_4-1.4.pdf
299507 PHS398_ModularBudget_1_2-1.2.pdf
299507 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299507 RR_SF424_2_0-2.0.pdf
299507 PHS398_CoverPageSupplement_5_0-5.0.pdf
299507 RR_OtherProjectInfo_1_4-1.4.pdf
299507 PerformanceSite_2_0-2.0.pdf
299507 RR_KeyPersonExpanded_2_0-2.0.pdf
299507 PHS398_ResearchPlan_4_0-4.0.pdf
299507 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299507 RR_Budget_1_4-1.4.pdf
299507 RR_SubawardBudget30_1_4-1.4.pdf
299507 PHS398_ModularBudget_1_2-1.2.pdf
299507 PHS_AssignmentRequestForm_3_0-3.0.pdf